Back to Authors
0000-0003-0114-5570
Mayo Clinic
Alnylam Pharmaceuticals (United States)
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
10.1212/wnl.96.15_supplement.1547